Specialty Enzymes Market Overview, Top Players Analysis, Business Development Strategies and Sales Revenue 2027 | Novozymes, DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies

According to a new report by Allied Market Research titled, "Specialty Enzymes Market -Global Opportunity Analysis and Industry Forecast, 2014 - 2027", the global specialty enzymes market is expected to register a CAGR of 9.4% during 2015-2027.

Download Free Sample Report @

https://www.alliedmarketresearch.com/request-sample/703

Specialty enzymes are proteins that act as biocatalysts to accelerate chemical reaction and produce the desired results. Owing to low consumption and high degree of specificity, specialty enzymes are witnessing spurring demand in medical applications such as pharmaceutical, biotechnology research and diagnostics. The growing popularity of specialty enzymes in therapies for chronic diseases such as cancer, cardiovascular diseases, pain and inflammatory disorders among others is the vital force fuelling the market growth. In addition, growing awareness about enzyme-based therapeutics in the Asia Pacific and LAMEA region would further boost the market growth. However, safety concerns due to high vulnerability of enzymes towards contamination, would limit the overall market growth.

Key findings of Specialty Enzymes Market:

Pharmaceutical application segment is projected to register a CAGR of 9.7%, fastest among all application types

Proteases enzyme would emerge as one of the most lucrative segments in the global specialty enzyme market by 2020

Animal derived enzymes is projected to grow at a significant rate in global specialty enzyme source market

North America and Europe collectively accounted for around 2/3rd of the global pharmaceutical specialty enzymes market in 2014, and are expected to maintain their lead throughout the analysis period

Inquiry for Buying @

https://www.alliedmarketresearch.com/purchase-enquiry/703

Rise in ageing population in developed economies such as North America and Europe, leads to an increased demand for therapeutic enzymes. Furthermore, adoption of advanced enzymes such as immobilized enzymes is increasing chiefly due to high healthcare expenditure. This had led to the dominance of North America in global specialty enzymes market closely followed by Europe. However, Asia-Pacific region exhibits the highest growth potential in future, due to the increasing per capita healthcare expenditure, increasing awareness about enzyme therapy and rapidly increasing pharmaceutical manufacturing base.

Companies are adopting acquisition and product launch as few of their key strategies to increase the manufacturing capacity, expand their market presence and gain additional market share. Key companies profiled in the report are Novozymes, DuPont, Roche Holdings AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix Inc, and Codexis Inc.

To know more about the report, visit the website at

https://www.alliedmarketresearch.com/specialty-enzymes-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.